Correlation of genetic instability and apoptosis in the presence of oncogenic Ki-Ras

Cell Death and Differentiation

Volumn 5, Issue 11, 1998, Pages 984-995

  Chen, Chang Yan ^a   Liou, James ^a   Forman, Lora W ^a   Faller, Douglas V ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; CAD gene amplification; Clonogenicity; Genomic instability; p53; ras oncogene; Tumor suppressors

Indexed keywords

PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE G1 PHASE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FIBROBLAST CULTURE; GENE AMPLIFICATION; GENETIC STABILITY; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROTO ONCOGENE; SIGNAL TRANSDUCTION; STRESS; TUMOR SUPPRESSOR GENE;

EID: 0031771114     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400448     Document Type: Article

References (87)

1. Arber N, Sutter T, Miyake M Kahn SM, Venkatraj VS, Sobrino A, Warburton D, Holt PR and Weinstein BI (1996) Increased expression of cyclin D1 and the Rb tumor suppressor gene in c-k-ras transformed rat enterocytes. Oncogene 12: 1903-1908
2. Askew DS, Ashmun RA, Simmons BC, and Cleveland JL (1991) Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6: 1915-1922
3. Avruch J, Zhang X and Kyriakis JM (1994) Raf meets Ras. completing the framework of a signal transduction pathway Trends in Biochem Sci. 19: 279-283
4. Ayusawa D, Shimizu K, Koyama H, Takeishi K and Seno T (1983) Accumulation of DNA strand breaks during thymineless death in thymidylate synthase-negative mutants of mouse FM3A cells J. Biol. Chem. 258: 12448-12454
5. Barbacid M (1987) ras genes Annual Review of Biochemistry pp 779-827
6. Bar-Sagi D and Feramisco JR (1985) Microinjection of the ras oncogene protein into PC12 cell induces morphological differentiation. Cell 42: 841-848
7. Bouffler SD, Kemp CJ, Balman A and Cox K (1995) Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice. Cancer Res. 55: 3883-3889
8. Buday L and Downward J (1993) Epidermal growth factor regulates the exchange rate of guanine nucleotides on p21 Ras in fibroblasts. Mol. Cell. Biol. 13: 1903-1910
9. Bourne HR, Wrischnik L and Kenyon C (1990) Ras proteins Some signal developments Nature 348: 678-679
10. Cahilly-Snyder L, Yang-Feng T, Fancke U and George DL (1987) Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Somat Cell Mol. Genet. 13: 235-244
11. Carder P, Wyllie AH, Purdie CA, Morris RG, White S, Pins J and Bird CC (1993) Stabilized p53 facilitates aneuploid clonal divergence in colorectal cancer. Oncogene 5: 1397-1401
12. Chen C-Y and Geard CR (1990) Relationship between cell survival and the incidence of micronuclei after low and high dose rate γ-irradiation of normal human fibroblasts. Radiat. Res. 124: 125-132
13. Chen C-Y and Faller DV (1995) Direction of p21 Ras-generated signals cell growth or apoptosis is determined by protein kinase C and Bcl-2. Oncogene 11: 1487-1498
14. Chen C-Y and Faller DV (1996) Phosphorylation of Bcl-2 protein and association with p21Ras in Ras-induced apoptosis. J. Biol. Chem. 271: 2376-2379
15. Chen C-Y, Liou J, Forman LW, and Faller DV (1998) Differential regulation of discrete apoptotic pathways by Ras. J. Biol. Chem., in press
16. Chin K-V, Ueda K, Pastan I and Gottesman MM (1992) Modulation of activity of the promoter of the human MDRI gene by Ras and p53 Science 255: 459-462
17. Denko NC, Giaccia AJ, Stnnger JR and Stambrook PJ (1994) The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle. Proc Natl. Acad. Sci. USA 91: 5124-5128
18. de Vries JE, Komips FHAC, Marx P, Bosman FT, Geraedts JPM and Kate JT (1993) Transfected c-Ha-ras oncogene enhances karyotypic instability and integrates predominantly in aberrant chromosomes. Cancer Genet Gyotgenet. 65: 35-43
19. Donehower LA, Godley LA, Aldaz CM, Pyle R, Shi Y-P, Pinkel D, Gray J, Bradley A, Medina D and Varmus HE (1995) Deficiency of p53 accelerates mammary tumongenesis in wnt-1 transgenic mice and promotes chromosomal instability. Genes. Dev. 9: 882-895
20. Downward J, Graves JD, Warne PH, Rayter S and Cantrell DA (1990) Stimulation of p21 Ras upon T-cell activation. Nature 346: 719-723
21. Ehyahu D, Michalovitz D, Eliyahu S, Pinhasi-Kimhi O and Oren M (1989) Wild-type p53 can inhibit oncogene-mediated focus formation. Proc. Natl. Acad. Sci. USA 86: 8763-8767
22. Evan GI, Wyllie AH, Gilbert CS, Littlewood TK, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128
23. Fakharzadeh SS, Trusko SP and George DL (1991) Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J. 10: 1565-1569
24. Faller DV, Mundschau LJ, Forman LW and Quinones MA (1994) v-mos suppresses platelet-denved growth factor (PDGF) type-beta receptor autophosphorylation and inhibits PDGF-BB-mediated signal transduction. J. Biol. Chem. 269: 5022-5029.
25. Feinberg AP and Volgelstein B (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132: 6-13
26. Filmus J, Robles AI, Shi W, Wong MJ, Colombo LL and Conti CJ (1994) Induction of cyclin D1 overexpression by activated ras. Oncogene 9: 3629-3633
27. Finlay CA, Hinds PW and Levine AJ (1989) The p53 proto-oncogene can act as a suppressor of transformation. Cell 57: 1083-1093
28. Fisher DE (1994) Apoptosis in cancer therapy: crossing the threshold Cell 78: 539-542
29. Fornace AJ, Alamo I and Hollander MC (1988) DNA damage-inducible transcripts in mammalian cells. Proc. Natl Acad. Sci USA 85: 8800-8804
30. Fornace AJ, Nebert D, Hollander MC, Papathanasiou M, Fargnoli J and Holbrook N (1989) Mammaliam genes coordinately regulated by growth arrest signals and DNA-damaging agents. Mol. Cell. Biol. 9: 4196-4203
31. Gulbins E, Bissonnette R, Mahoubi A, Martin S, Nishioka W, Brunner T, Baier G, Baier-Bitterlich G, ByrdC, Lang F, Kolesnick R and Green D (1995) Fas-induced apoptosis is mediated via a ceramide-initiated Ras signaling pathway. Immunity 2: 341-351
32. Hall EJ (1994) Radiobiology for the radiologist, Philadelphia: J. B. Lippincott company pp. 245-256
33. Hallberg B, Rayter SI and Downward J (1994) Interaction of Ras and Raf in intact mammalian cells upon extracellular stimulation. J Biol. Chem. 269: 3913-3916
34. Harnngton EA, Bennett MR, Fanidi A and Evan GI (1994) c-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines EMBO J. 13: 3286-3295
35. Harris CC and Hellstein M (1993) Clinical implication of the p53 tumor suppressor gene. N. Engl. J. Med. 329: 1318-1327
36. Hartwell LH and Weinert TA (1989) Checkpoints: controls that ensure the order of cell cycle events Science 246: 629-634
37. Hartwell LH (1992) Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71: 543-546
38. Hartwell LH and Kastan MB (1994) Cell cycle control and cancer. Science 266: 1821-1828
39. Hattori S, Fukuda M, Yamashita T, Nakamura S, Gotoh Y and Hishida E (1992) Activation of mitogen-activated protein kinase and its activator by ras in intact cells and in a cell-free system J. Biol. Chem. 267: 20436-20351
40. Hick GG, Egan SE, Greenberg AH and Mowat M (1991) Mutant p53 tumor suppressor alleles release ras-induced cell cycle growth arrest. Mole. Cell. Biol. 11: 1344-1352
41. Hirakawa T and Ruley HE (1988) Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene. Proc. Natl. Acad. Sci USA 85: 1519-1523
42. Hollstein M, Shomer B, Greenblatt M, Soussi T, Hovig E, Montesano R and Harris CC (1996) Somatic point mutations in the p53 gene of human tumors and cell lines. updated compilation. Nucleic Acids Res. 24: 141-146
43. Kastan MB, Zhan Q, El-Deiry WS, Camer F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace AJ (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in Ataxia-Telangiectasia. Cell 71: 587-597
44. Kelly RE, DeRose ML, Draper BW and Wahl GM (1995) Identification of an origin of bidirectional DNA replication in the ubiquitously expressed mammalian CAD gene. Mol. Cell. Biol. 15: 4136-4148
45. Khosravi-Far R and Der CJ (1994) The Ras signal transduction pathway. Cancer and Metastasis Rev. 13: 67-89
46. Koyama H, Ayusawa D, Tsuji M and Seno T (1982) Thymineless death and mutation induction in cultured mouse FM3A cell mutants deficient in thymidylate synthase. Mutat. Res. 105: 433-438
47. Lee JM, Abrahamson JL, Kandel R, Donehower LA and Bernstein A (1994) Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice Oncogene 9: 3731-3736
48. Li B-Q, Kaplan D, Kung H-F and Kamata T (1992) Nerve growth factor stimulation of the Ras-guanine nucleotide exchange factor and GAP activities. Science 256: 1456-1459
49. Liu J-J, Chao J-R, Jiang M-C, Ng S-Y, Yen JJ and Yen HEY (1995) Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH-3T3 cells Mol. Cell. Biol 15: 3654-3663
50. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T and Tlsty TD (1992) Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70: 923-935
51. Lovec H, Sewing A, Lucibello FC, Muller R and Moroy T (1994) Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene 9: 323-326
52. Lu X, Park SH, Thompson TC and Lane P (1992) Ras-induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation. Cell 70: 153-161
53. Marshall MS (1993) The effector interactions of p21 Ras. Trends Biochem. Sci 18: 250-254
54. Marx J (1994) New link found between p53 and DNA repair. Science 266: 1321-1322
55. McCormick F (1994) Activators and effectors of ras p21 proteins. Curr. Opin Genet. Dev 4: 82-96
56. McKenna WG, Bernhard EJ, Markiewicz DA, Rudoltz MS, Maity A and Muschel RJ (1996) Regulation of radiation-induced apoptosis in oncogene-transfected fibroblasts. influence of Ha-ras on the G2 delay. Oncogene 12: 237-245
57. Medema RH, de Vries-Smits AMM, ven der Zon GCM, Maassen JA and Bos JL (1993) Role of p21 Ras in growth factor signal transduction. Mol. Cell. Biol. 13: 155-162
58. Moll UM, Ostermeyer AG, Haladay R, Winkfield B, Frazier M and Zambetti G (1996) Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage Mol. Cell. Biol. 16: 1126-1137
59. Momand J, Zambett GP, Olson DC, George D and Levine AJ (1991) The mdm-2 oncogene product transactivation. Cell 69: 1237-1245
60. Moodie SA, Willumsen BM, Weber MJ and Wolfman A (1993) Complexes of Ras-GTP with Raf-1 and mitogen-activated protein kinase. Science 260: 1658-1661
61. Moyer JD, Smith PA, Levy EJ and Handschumacher RE (1982) Kintics of N-(phosphonacetyl)-L-aspartate and pyrazofurin depletion of pynmidine ribonucleotide and deoxyribonucleotide pools and their relationship to nucleic acid synthesis in intact and permeabilized cells. Cancer Res. 42: 4525-4531
62. Phelps WC, Yee CC, Munger K and Howley PM (1989) The human papillomavirus type 16E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A Cell 53: 539-547
63. Prives C (1993) Doing the right things, feedback control and p53. Curr. Opinion in Cell Biology 5: 214-218
64. Prives C (1994) How loops, βsheets, and α helices help us to understand p53. Cell 78: 543-546
65. Ridley AJ, Paterson HF, Noble M and Lane H (1988) Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. EMBO J 7: 1635-1645
66. Schaefer DI, Livanos EM, White AE and Tlsty TD (1993) Multiple mechanisms of N-(phosphonoacetyl)-L-aspartate drug resistance in SV40-infected precrisis human fibroblasts. Cancer Res 53: 4946-4951
67. INK4. Science 267: 249-252
68. Serrano M, Lee HW, Chin L, Cordon-Cardo C, Beach Dand DePinho RA (1996) Role of the INK4a locus in tumor suppression and cell mortality Cell 85: 27-37
69. Serrano M, Lin AW, McCurrach ME, Beach D and Lowe SW (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602
70. Sherr CJ and Roberts JM (1995) Inhibitors of mammalian G1 cyclin-dependent kinases Gene & Devel. 9: 1149-1163
71. Shi, YF, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP and Green DR (1992) Role for c-myc in activation-induced apoptotic cell death in T-cell hybridomas. Science 257: 212-214
72. Smith ML, Chen I-T, Zhan Q, Bae I, Chen C-Y, GilmerTM, Kastan MB, O'Connor PM and Fornace AJ (1994) Interaction of the p53-regulated protein GADD45 with proliferating cell nuclear antigen. Science 266: 1376-1380
73. Stark GR (1993) Regulation and mechanisms of mammalian gene amplification. Genetics in Cancer Res. 61: 87-113
74. Storey A, Pim D, Murray A, Osborn K, Banks L and Crawford L (1988) Comparison of the in vitro transforming activities of human papillomavirus types. EMBO J. 7: 1815-1820
75. Tanaka N, Ishihara M, Kitagawa M, Harada H, KimuraT, Matsuyama T, Lamphier MS, Aizawa S, Mak TW and Taniguchi T (1994) Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77: 829-839
76. Tlsty TD, Margolin BH and Lum K (1989) Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbruck fluctuation analysis. Proc. Natl Acad. Sci USA 86: 9441-9445
77. Tlsty TD (1990) Normal diploid human and rodent cells lack a detectable frequency of gene amplification. Proc. Natl. Acad Sci. USA 87: 3132-3136
78. Vogelstein B and Kinzler KW (1992) p53 function and dysfunction. Cell 70: 523-526
79. Vojtek AB, Hollenberg SM and Cooper JA (1993) Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74: 205-214
80. Walker GC (1984) Mutagenesis and inducible responses to DNA damage in E. coli. Microbiol Rev. 48: 60-93
81. Wang XW, Yeh H, Schaeffer L, Moncollin V, Egly J-M, Wang z, Friedberg EC and Harris CC (1995) p53 modulation of RFIIH-associated nucleotide excision repair activity. Nature Genetics. 10: 188-195
82. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81: 323-330
83. Windle B, Draper BW, Yin X, O'Gorman S and Wahl GM (1991) A central role for chromosome breakage in gene amplification, deletion formation, and amplicon integration. Gene. Dev. 5: 160-174
84. Winston JT, Coats SR, Wang Y-Zand Pledger WJ (1996) Regulation of the cell cycle machinery by oncogenic ras. Oncogene 12: 127-134
85. Yin Y, Tainsky MA, Bischoff FZ, Strong LC and Wahl GM (1992) Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles Cell 70: 937-948
86. Zhang K, Papageorge AG and Lowy DR (1992) Mechanistic aspects of signaling through Ras in NIH3T3 cells. Science 257: 671-674
87. Zullo JN and Faller DV (1988) p21 v-ras inhibits induction of c-myc and c-fos expression by platelet-derived growth factor. Mol. Cell. Biol 8: 5080-5085